Pharmanutra

Regulatory Filings • Jun 3, 2025

Informazione Regolamentata n. 20106-32-2025	Data/Ora Inizio Diffusione 3 Giugno 2025 08:00:05		Euronext Star Milan
Societa'	:	PHARMANUTRA
Identificativo Informazione Regolamentata	:	206489
Utenza - referente	:	PHARMANUTRAN04 - Roberto Lacorte
Tipologia	:	REGEM
Data/Ora Ricezione	:	3 Giugno 2025 08:00:05
Data/Ora Inizio Diffusione	:	3 Giugno 2025 08:00:05
Oggetto	:	Pharmanutra: Launch of ApportAL Boost
Testo del comunicato

Vedi allegato

PHARMANUTRA S.P.A. LAUNCHES THENEW NUTRITIONAL SUPPLEMENT APPORTAL® BOOST

THE PISA-BASED COMPANY EXPANDS ITS APPORTAL® LINE WITH A THIRD PRODUCT, A NUTRITIONAL SUPPLEMENT CONTAINING 22 FUNCTIONAL INGREDIENTS TO OFFER FAST AND EFFECTIVE SUPPORT FOR THE BODY'S PHYSICAL AND MENTAL CAPACITIES

Pisa, 3 June 2025 –PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialised in mineral-based nutritional supplements and medical devices for muscles and joints, announces the launch of its expanded product range with the introduction of the new Apportal® Boost dietary supplement, designed and developed to provide a quick and effective supply when the body needs energy, strength and protection.

Apportal® Boost, the third product in the Apportal® line, is a unique formulation: a single sachet contains 22 nutrients, including Carnitine, Ginseng, NADH, Ribose, Royal Jelly, as well as Vitamin D3 and Vitamin B12 in Sucrosomal® form. These principles, combined with five minerals also developed with Sucrosomial® Technology (Selenium, Iron, Zinc, Magnesium, Iodine), create a 'pro-energizing' effect, providing the body the boost it needs in cases of fatigue, intense physical activity or when it needs to perform at its best, to regain focus and concentration. This rapid effect is possible thanks to the combination of highly energising nutrients together with Sucrosomal® Technology, an exclusive PharmaNutra, which improves the absorption and tolerability of micro- and macro-nutrients.

In Apportal® Boost, all the nutrients within the formulation work synergistically to be effectively absorbed and tolerated, providing an instant energy boost that supports the body during daily activities. Apportal® Boost is now on the market with a marketing campaign that includes, in addition to the classic channels of pharmacies and online stores, direct sales via PharmaNutra's Amazon store. More in-depth information and details can be found at www.apportal.it .

Andrea Lacorte, President of PharmaNutra S.p.A., states: "Apportal® Boost represents the ultimate expression of PharmaNutra's technology, but not only. It is a unique and exclusive product because, thanks to our in-house patented Sucrosomial® Technology, we were able to put as many as 22 elements together in one product. It is, in fact, a formulation that is completely impossible to replicate industrially without the use of our patent, which allows the integration of all Sucrosomial® minerals with the other ingredients. As of today, Apportal® Boost is, therefore, the most comprehensive energy metabolism stimulator on the market, with one major difference from all other products on the market: the Boost does not provide direct energy through carbohydrates or nutrients but acts by lubricating and speeding up the intrinsic energy metabolism, as if all its gears were running at an accelerated speed. We talk about speed of action, and this is a really new concept, because without elements such as caffeine, carbohydrates or other stimulants, we are able to speed up energy

PharmaNutra S.p.A.

metabolism extremely quickly and effectively. Clearly this is a very complex formulation to make, and it involved a year and a half of pharmaceutical work in addition to research, but we finally got there, and we are very, very pleased with the final result".

Roberto Lacorte, Vice-President of PharmaNutra, adds: "With the new Apportal® Boost, we are launching worldwide a product dedicated to all those people who need a very fast and effective response to fatigue and energy metabolism, and I'm not just referring to those who practice sport. It is a supplement that is unparalleled in the market, because thanks to the use of our Sucrosomial® Technology - and without the use of stimulants we have managed to create a product that, in terms of effectiveness and speed of action, is incomparable. When we talk about strategic corporate assets, with reference to Sucrosomial® Technology, we are referring precisely to this, to the possibility of presenting ourselves on the market with products that from a scientific and nutritional point of view are unique, and therefore not replicable. With Apportal® Boost, we have succeeded in making the human organism, hence our engine, more efficient with nutritional engineering that represents a milestone in the industry".

PharmaNutra S.p.A.

Founded and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra is a company established in 2003 that develops unique nutritional supplements and innovative medical devices, taking care of the entire production process. PharmaNutra is a leader in the production of iron-based nutritional supplements under the SiderAL® brand, where it holds important patents on Sucrosomial® Technology, and is considered one of the emerging top players in the medical device sector dedicated to restoring joint capacity thanks to the Cetilar® brand. The latter is now also on the market in the Nutrition version: a line of food supplements designed for those who practice sport frequently. Over the years, the Group present abroad in 89 countries - has developed a precise strategy in the production of intellectual property, based on the integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence. PharmaNutra.it

For further details:

Via Campodavela, 1 - 56122 Pisa, Italy Tel. +39 050 7846500 investorrelation@PharmaNutra.it

Internal Press Office

press@calabughi.com

PharmaNutra S.p.A. Press Office - Spriano Communication & Partners

Via Santa Radegonda, 16 - 20121 Milan, Italy Tel. +39 02 83635708

Matteo Russo mrusso@sprianocommunication.com Cristina Tronconi ctronconi@sprianocommunication.com

PharmaNutra S.p.A. Registered office Via Campodavela, 1 - 56122 Pisa, Italy | +39 050 7846500 pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it Tax ID no. / VAT no. / Trade Reg. no. 01679440501 - SDI Code SUBM70N Sh. Cap. 1,123,097.70 € fully paid in | REA Economic and Administrative Index 146259

PharmaNutra S.p.A.

Registered office Via Campodavela, 1 - 56122 Pisa, Italy | +39 050 7846500 pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it Tax ID no. / VAT no. / Trade Reg. no. 01679440501 - SDI Code SUBM70N Sh. Cap. 1,123,097.70 € fully paid in | REA Economic and Administrative Index 146259

Fine Comunicato n.20106-32-2025	Numero di Pagine: 5
---------------------------------	---------------------